$2.59 Billion is the total value of Artal Group S.A.'s 99 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 48.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BGNE | Sell | BEIGENE LTDsponsored adr | $106,086,000 | +33.3% | 640,000 | -1.5% | 4.10% | +28.4% |
| AVTR | Sell | AVANTOR INC | $86,213,000 | -2.3% | 4,750,000 | -20.8% | 3.33% | -5.8% |
| XLRN | Sell | ACCELERON PHARMA INC | $63,624,000 | +7.4% | 1,200,000 | -20.0% | 2.46% | +3.5% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $32,044,000 | -27.3% | 400,000 | -33.3% | 1.24% | -29.9% |
| TPTX | Sell | TURNING POINT THERAPEUTICS I | $18,687,000 | +24.2% | 300,000 | -25.0% | 0.72% | +19.7% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $15,560,000 | -8.3% | 250,000 | -50.0% | 0.60% | -11.6% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $13,912,000 | -3.7% | 100,000 | -33.3% | 0.54% | -7.3% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $13,840,000 | +8.6% | 500,000 | -28.6% | 0.54% | +4.7% |
| HOOK | Sell | HOOKIPA PHARMA INC | $12,291,000 | +44.4% | 1,004,987 | -11.4% | 0.48% | +39.3% |
| DRNA | Sell | DICERNA PHARMACEUTICALS INC | $11,015,000 | -23.3% | 500,000 | -50.0% | 0.43% | -26.0% |
| NKTR | Sell | NEKTAR THERAPEUTICScall | $10,793,000 | -1.2% | 500,000 | -16.7% | 0.42% | -4.8% |
| INCY | Sell | INCYTE CORPcall | $8,732,000 | -52.9% | 100,000 | -60.0% | 0.34% | -54.7% |
| TGTX | Sell | TG THERAPEUTICS INC | $7,215,000 | +42.8% | 650,000 | -27.8% | 0.28% | +37.4% |
| IGMS | Sell | IGM BIOSCIENCES INC | $5,724,000 | +61.2% | 150,000 | -25.0% | 0.22% | +55.6% |
| TCRR | Sell | TCR2 THERAPEUTICS INC | $5,712,000 | -19.5% | 400,000 | -15.2% | 0.22% | -22.2% |
| TBIO | Sell | TRANSLATE BIO INC | $5,291,000 | -28.8% | 650,000 | -13.3% | 0.20% | -31.5% |
| SPRO | Sell | SPERO THERAPEUTICS INC | $4,808,000 | -16.0% | 500,000 | -7.4% | 0.19% | -18.8% |
| KRYS | Sell | KRYSTAL BIOTECH INC | $4,430,000 | -15.0% | 80,000 | -46.7% | 0.17% | -18.2% |
| REAL | Sell | THE REALREAL INC | $3,770,000 | -70.2% | 200,000 | -64.6% | 0.15% | -71.2% |
| KLDO | Sell | KALEIDO BIOSCIENCES INC | $2,513,000 | -62.9% | 500,500 | -44.4% | 0.10% | -64.3% |
| AVRO | Exit | AVROBIO INC | $0 | – | -23,449 | -100.0% | -0.01% | – |
| SQ | Exit | SQUARE INCcl a | $0 | – | -30,000 | -100.0% | -0.08% | – |
| GRTS | Exit | GRITSTONE ONCOLOGY INC | $0 | – | -250,000 | -100.0% | -0.09% | – |
| ALLO | Exit | ALLOGENE THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.11% | – |
| NIO | Exit | NIO INCsponsored ads | $0 | – | -2,000,000 | -100.0% | -0.12% | – |
| TORC | Exit | RESTORBIO INC | $0 | – | -500,000 | -100.0% | -0.18% | – |
| ARQL | Exit | ARQULE INC | $0 | – | -850,000 | -100.0% | -0.24% | – |
| NKTR | Exit | NEKTAR THERAPEUTICS | $0 | – | -500,000 | -100.0% | -0.36% | – |
| BOLD | Exit | AUDENTES THERAPEUTICS INC | $0 | – | -350,000 | -100.0% | -0.39% | – |
| FIS | Exit | FIDELITY NATL INFORMATION SV | $0 | – | -75,000 | -100.0% | -0.40% | – |
| DLPH | Exit | DELPHI TECHNOLOGIES PLCcall | $0 | – | -750,000 | -100.0% | -0.40% | – |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -0.62% | – |
| BABA | Exit | ALIBABA GROUP HLDG LTDcall | $0 | – | -100,000 | -100.0% | -0.67% | – |
| GBT | Exit | GLOBAL BLOOD THERAPEUTICS IN | $0 | – | -350,000 | -100.0% | -0.68% | – |
| XBI | Exit | SPDR SERIES TRUSTcall | $0 | – | -250,000 | -100.0% | -0.76% | – |
| NVDA | Exit | NVIDIA CORP | $0 | – | -200,000 | -100.0% | -1.40% | – |
| MDCO | Exit | MEDICINES CO | $0 | – | -1,400,000 | -100.0% | -2.81% | – |
| BAC | Exit | BANK AMER CORPcall | $0 | – | -3,000,000 | -100.0% | -3.51% | – |
| BMY | Exit | BRISTOL MYERS SQUIBB COcall | $0 | – | -3,500,000 | -100.0% | -7.12% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AGENUS INC | 42 | Q3 2023 | 1.9% |
| IRONWOOD PHARMACEUTICALS INC | 42 | Q3 2023 | 0.3% |
| ALNYLAM PHARMACEUTICALS INC | 37 | Q3 2023 | 5.1% |
| LEXICON PHARMACEUTICALS INC | 34 | Q3 2023 | 20.6% |
| AMICUS THERAPEUTICS INC | 30 | Q3 2023 | 2.7% |
| BEIGENE LTD | 28 | Q3 2023 | 7.4% |
| BK OF AMERICA CORP | 28 | Q1 2021 | 4.3% |
| SAGE THERAPEUTICS INC | 28 | Q2 2023 | 1.9% |
| AGIOS PHARMACEUTICALS INC | 28 | Q2 2020 | 1.1% |
| NEKTAR THERAPEUTICS | 27 | Q2 2020 | 1.3% |
View Artal Group S.A.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| WEIGHT WATCHERS INTERNATIONAL INC | February 13, 2015 | 29,443,300 | 51.9% |
View Artal Group S.A.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-25 |
| 4 | 2024-03-13 |
| 4 | 2024-02-29 |
| 13F-HR | 2024-02-09 |
| 13F-HR | 2023-11-13 |
| 4 | 2023-10-16 |
| 13F-HR | 2023-08-11 |
| 4 | 2023-06-22 |
| 3 | 2023-06-15 |
| 4 | 2023-06-05 |
View Artal Group S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.